Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
+$464M |
| 2 |
Exxon Mobil
XOM
|
+$299M |
| 3 |
FedEx
FDX
|
+$289M |
| 4 |
Netflix
NFLX
|
+$273M |
| 5 |
Micron Technology
MU
|
+$265M |
Top Sells
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$285M |
| 3 |
Mastercard
MA
|
+$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
TAL Education Group
TAL
$6.54B
| $479K | ﹤0.01% |
14,200
-775,400
| -98% | -$26.2M |
|
2802
Green Brick Partners
GRBK
$3.28B
| $478K | ﹤0.01% |
48,251
+21,614
| +81% | +$214K |
|
|
ZGNX
2803
DELISTED
Zogenix, Inc.
ZGNX
| $476K | ﹤0.01% |
+13,587
| New | +$476K |
|
2804
Genasys
GNSS
$97.5M
| $475K | ﹤0.01% |
223,200
-15,900
| -7% | -$33.8K |
|
|
SA
2805
Seabridge Gold
SA
$1.9B
| $475K | ﹤0.01% |
38,805
-12,200
| -24% | -$149K |
|
2806
Imunon
IMNN
$14.2M
| $473K | ﹤0.01% |
1,613
+479
| +42% | +$140K |
|
|
NBLX
2807
DELISTED
Noble Midstream Partners LP
NBLX
| $472K | ﹤0.01% |
9,100
-26,525
| -74% | -$1.38M |
|
2808
ReposiTrak
TRAK
$314M
| $469K | ﹤0.01% |
38,600
-17,627
| -31% | -$214K |
|
|
CMBT
2809
CMB.TECH NV
CMBT
$2.72B
| $467K | ﹤0.01% |
57,600
+11,200
| +24% | +$90.8K |
|
2810
Meritage Homes
MTH
$5.77B
| $466K | ﹤0.01% |
+21,000
| New | +$466K |
|
|
LMRK
2811
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $466K | ﹤0.01% |
27,500
+4,900
| +22% | +$83K |
|
|
GLBR
2812
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $465K | ﹤0.01% |
281,730
+10,500
| +4% | +$17.3K |
|
2813
Xenon Pharmaceuticals
XENE
$2.87B
| $461K | ﹤0.01% |
156,400
+26,100
| +20% | +$76.9K |
|
|
PFBX
2814
DELISTED
Peoples Financial Corp/MS
PFBX
| $460K | ﹤0.01% |
31,300
+1,100
| +4% | +$16.2K |
|
2815
ArcBest
ARCB
$1.67B
| $458K | ﹤0.01% |
13,700
-87,435
| -86% | -$2.92M |
|
|
STRM
2816
DELISTED
Streamline Health Solutions
STRM
| $456K | ﹤0.01% |
20,699
+752
| +4% | +$16.6K |
|
2817
MediWound
MDWD
$207M
| $455K | ﹤0.01% |
12,157
+714
| +6% | +$26.7K |
|
2818
Plumas Bancorp
PLBC
$317M
| $451K | ﹤0.01% |
21,600
+9,010
| +72% | +$188K |
|
|
CRT
2819
Cross Timbers Royalty Trust
CRT
$48.2M
| $448K | ﹤0.01% |
30,694
+12,782
| +71% | +$187K |
|
|
NRCIB
2820
DELISTED
National Research Corp Class B
NRCIB
| $446K | ﹤0.01% |
8,343
+2,343
| +39% | +$125K |
|
|
CYAN
2821
DELISTED
Cyanotech Corp
CYAN
| $442K | ﹤0.01% |
109,000
+4,000
| +4% | +$16.2K |
|
|
JMP
2822
DELISTED
JMP Group LLC
JMP
| $442K | ﹤0.01% |
78,733
+13,119
| +20% | +$73.6K |
|
|
WAAS
2823
DELISTED
AquaVenture Holdings Limited
WAAS
| $439K | ﹤0.01% |
32,500
-40,700
| -56% | -$550K |
|
|
ARCW
2824
DELISTED
ARC Group Worldwide, Inc
ARCW
| $439K | ﹤0.01% |
186,600
+300
| +0.2% | +$706 |
|
2825
Eledon Pharmaceuticals
ELDN
$152M
| $437K | ﹤0.01% |
4,660
+1,172
| +34% | +$110K |
|